23.4 C
New York
Monday, June 15, 2026

Tag: chest

newssourceFORcompanyinformationcontent1marketreleases

Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology

SAN FRANCISCO, July 16, 2025 /PRNewswire/ -- Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance...

Johnson & Johnson Launches VARIPULSE™ Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency,...

National Heart, Lung, and Blood Institute / National Institutes of Health Signs Clinical Trial Agreement with Vascarta Inc. to Perform Phase 1 Clinical Study...

SUMMIT, N.J., July 7, 2025 /PRNewswire/ -- Under the agreement, the National Heart, Lung, and Blood Institute / National Institutes of Health will perform...

Public Advisory – NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drug

OTTAWA, ON, July 5, 2025 /CNW/ - Summary Product: NRA-Amlodipine 5 mg, DIN 02476460Issue: Health products - Product safetyWhat to do: Check your bottle of NRA-Amlodipine 5 mg...

RITFIT’s 2025 Strategy: Elevating Home Fitness with Personalized, Professional-Grade Equipment

LOUISVILLE, Ky., July 4, 2025 /PRNewswire/ -- RITFIT, a leading global home fitness brand, has made a groundbreaking announcement at the HomeGymCon 2025, revealing its...

Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai

SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative...

HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line...

— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —

Dr. Juan Pablo Umaña Joins the Miller School and UHealth as Chief of Cardiothoracic Surgery

MIAMI, June 23, 2025 /PRNewswire/ -- The Miller School of Medicine and UHealth – University of Miami Health System welcome Juan Pablo Umaña, M.D., an...

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing

Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient...

IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly...

The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control...

European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Haematopoietic Sub-syndrome...

LEXINGTON, Mass., June 20, 2025 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx) today announced that the Committee for Medicinal Products for Human Use (CHMP) of...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Haier Ranks First in Industry on the Top 50 2025 Chinese Global Brand Builders List, Maintains Top 10 Position for 9 Consecutive Years

LINGSHUI, China, June 19, 2025 /CNW/ -- Haier has once again secured the top position in the home appliance category on the prestigious Top...

Huxley Medical Shares New Data at SLEEP Demonstrating Breadth of Clinical Insights Enabled by SANSA Diagnostic Platform

SEATTLE, June 18, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsChest

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers